BACKGROUND: The 10-item version of the cocaine craving questionnaire (CCQ-Brief) has not been validated in a mixed-gender sample, and predictive validity of the CCQ-Now and CCQ-Brief in terms of their relationship with cocaine relapse has not been demonstrated. OBJECTIVE: To further validate the CCQ-Brief in a mixed gender sample and to determine the predictive validity of the CCQ-Now and CCQ-Brief. METHOD: Seventy-two men and 51 women (Total N=123) seeking inpatient cocaine dependence treatment were administered assessments upon admission, and a prospective design was employed to assess cocaine relapse outcomes during a 90-day follow-up period after discharge from inpatient treatment. Data were analyzed using Pearson's correlation, Cox proportional hazards regression, and multiple regression. FINDINGS: The CCQ-Brief demonstrated good internal consistency and construct and concurrent validity. Both the CCQ-Now and the CCQ-Brief summary scores predicted time to cocaine relapse. In addition, the anticipation of a positive outcome from cocaine use, and intent and planning to use cocaine subscales of the CCQ-Now also predicted time to cocaine relapse. CONCLUSIONS: The CCQ-Brief was found to be a reliable and valid measure in a mixed gender sample, and both the CCQ-Now and CCQ-Brief were predictive of cocaine relapse risk. Craving assessments that go beyond desire and take into account intent and planning to use cocaine and the patient's anticipation of a positive outcome from using cocaine are likely to provide a sensitive index of cocaine relapse susceptibility. However, fear of social and clinical consequences could impact accurate reporting of cocaine craving and intent to use cocaine.
BACKGROUND: The 10-item version of the cocaine craving questionnaire (CCQ-Brief) has not been validated in a mixed-gender sample, and predictive validity of the CCQ-Now and CCQ-Brief in terms of their relationship with cocaine relapse has not been demonstrated. OBJECTIVE: To further validate the CCQ-Brief in a mixed gender sample and to determine the predictive validity of the CCQ-Now and CCQ-Brief. METHOD: Seventy-two men and 51 women (Total N=123) seeking inpatient cocaine dependence treatment were administered assessments upon admission, and a prospective design was employed to assess cocaine relapse outcomes during a 90-day follow-up period after discharge from inpatient treatment. Data were analyzed using Pearson's correlation, Cox proportional hazards regression, and multiple regression. FINDINGS: The CCQ-Brief demonstrated good internal consistency and construct and concurrent validity. Both the CCQ-Now and the CCQ-Brief summary scores predicted time to cocaine relapse. In addition, the anticipation of a positive outcome from cocaine use, and intent and planning to use cocaine subscales of the CCQ-Now also predicted time to cocaine relapse. CONCLUSIONS: The CCQ-Brief was found to be a reliable and valid measure in a mixed gender sample, and both the CCQ-Now and CCQ-Brief were predictive of cocaine relapse risk. Craving assessments that go beyond desire and take into account intent and planning to use cocaine and the patient's anticipation of a positive outcome from using cocaine are likely to provide a sensitive index of cocaine relapse susceptibility. However, fear of social and clinical consequences could impact accurate reporting of cocaine craving and intent to use cocaine.
Authors: Roger D Weiss; Margaret L Griffin; Carissa Mazurick; Benjamin Berkman; David R Gastfriend; Arlene Frank; Jacques P Barber; Jack Blaine; Ihsan Salloum; Karla Moras Journal: Am J Psychiatry Date: 2003-07 Impact factor: 18.112
Authors: K M Kampman; J R Volpicelli; D E McGinnis; A I Alterman; R M Weinrieb; L D'Angelo; L E Epperson Journal: Addict Behav Date: 1998 Jul-Aug Impact factor: 3.913
Authors: David A Smelson; Miklos F Losonczy; Craig W Davis; Maureen Kaune; John Williams; Douglas Ziedonis Journal: Can J Psychiatry Date: 2002-09 Impact factor: 4.356
Authors: David Smelson; Kevin W Chen; Douglas Ziedonis; Ken Andes; Amanda Lennox; Lanora Callahan; Stephanie Rodrigues; David Eisenberg Journal: J Altern Complement Med Date: 2012-07-03 Impact factor: 2.579
Authors: Hedy Kober; Peter Mende-Siedlecki; Ethan F Kross; Jochen Weber; Walter Mischel; Carl L Hart; Kevin N Ochsner Journal: Proc Natl Acad Sci U S A Date: 2010-08-02 Impact factor: 11.205
Authors: Kenzie L Preston; Massoud Vahabzadeh; John Schmittner; Jia-Ling Lin; David A Gorelick; David H Epstein Journal: Psychopharmacology (Berl) Date: 2009-09-24 Impact factor: 4.530